Iodine-131-meta-iodobenzylguanidine therapy for patients with high-risk neuroblastoma

Kathelijne C.J.M. Kraal; Elvira C. van Dalen; Godelieve A.M. Tytgat; Berthe L. Van Eck-Smit; Huib N. Caron

doi:10.1002/14651858.CD010349

Iodine-131-meta-iodobenzylguanidine therapy for patients with high-risk neuroblastoma

Kathelijne C.J.M. Kraal
, Elvira C. van Dalen
, Godelieve A.M. Tytgat
, Berthe L. Van Eck-Smit
, Huib N. Caron

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy of ¹³¹I-MIBG therapy in patients with newly diagnosed, relapsed and/or refractory high-risk NBL.

Original language	English
Article number	CD010349
Journal	Cochrane Database of Systematic Reviews
Volume	2013
Issue number	2
DOIs	https://doi.org/10.1002/14651858.CD010349
Publication status	Published - 28 Feb 2013
Externally published	Yes

Access to Document

10.1002/14651858.CD010349

Cite this

@article{e0d5febe3e004c0dbf914719139183ab,

title = "Iodine-131-meta-iodobenzylguanidine therapy for patients with high-risk neuroblastoma",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy of 131I-MIBG therapy in patients with newly diagnosed, relapsed and/or refractory high-risk NBL.",

author = "Kraal, \{Kathelijne C.J.M.\} and \{van Dalen\}, \{Elvira C.\} and Tytgat, \{Godelieve A.M.\} and \{Van Eck-Smit\}, \{Berthe L.\} and Caron, \{Huib N.\}",

note = "Publisher Copyright: {\textcopyright} 2013 The Cochrane Collaboration.",

year = "2013",

month = feb,

day = "28",

doi = "10.1002/14651858.CD010349",

language = "English",

volume = "2013",

journal = "Cochrane Database of Systematic Reviews",

issn = "1361-6137",

publisher = "John Wiley and Sons Ltd",

number = "2",

}

TY - JOUR

T1 - Iodine-131-meta-iodobenzylguanidine therapy for patients with high-risk neuroblastoma

AU - Kraal, Kathelijne C.J.M.

AU - van Dalen, Elvira C.

AU - Tytgat, Godelieve A.M.

AU - Van Eck-Smit, Berthe L.

AU - Caron, Huib N.

PY - 2013/2/28

Y1 - 2013/2/28

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy of 131I-MIBG therapy in patients with newly diagnosed, relapsed and/or refractory high-risk NBL.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy of 131I-MIBG therapy in patients with newly diagnosed, relapsed and/or refractory high-risk NBL.

UR - https://www.scopus.com/pages/publications/85048480307

U2 - 10.1002/14651858.CD010349

DO - 10.1002/14651858.CD010349

M3 - Article

AN - SCOPUS:85048480307

SN - 1361-6137

VL - 2013

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 2

M1 - CD010349

ER -

Iodine-131-meta-iodobenzylguanidine therapy for patients with high-risk neuroblastoma

Abstract

Access to Document

Fingerprint

Cite this